A detailed history of Croban transactions in Amgen Inc stock. As of the latest transaction made, Croban holds 3,887 shares of AMGN stock, worth $1.33 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
3,887
Previous 3,881 0.15%
Holding current value
$1.33 Million
Previous $1.08 Billion 1.23%
% of portfolio
0.73%
Previous 0.93%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$271.18 - $309.22 $1,627 - $1,855
6 Added 0.15%
3,887 $1.1 Billion
Q2 2025

Aug 08, 2025

BUY
$262.28 - $309.85 $15,212 - $17,971
58 Added 1.52%
3,881 $1.08 Billion
Q1 2025

Apr 30, 2025

SELL
$258.59 - $327.36 $775 - $982
-3 Reduced 0.08%
3,823 $1.19 Billion
Q4 2024

Aug 19, 2025

SELL
$258.78 - $328.31 $14,232 - $18,057
-55 Reduced 1.42%
3,826 $997 Million
Q4 2023

Feb 07, 2025

BUY
$255.7 - $288.46 $978,308 - $1.1 Million
3,826 New
3,826 $997 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Croban Portfolio

Follow Croban and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Croban, based on Form 13F filings with the SEC.

News

Stay updated on Croban with notifications on news.